Episode Details

Back to Episodes

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

Published 5 months, 1 week ago

Description

Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.

Show reference:

https://www.nejm.org/doi/10.1056/NEJMoa2413449

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.